|
1
|
Flegal KM, Carroll MD, Kuczmarski RJ and
Johnson CL: Overweight and obesity in the United States: prevalence
and trends, 1960–1994. Int J Obes Relat Metab Disord. 22:39–47.
1998.
|
|
2
|
Flegal KM, Carroll MD, Ogden CL and Curtin
LR: Prevalence and trends in obesity among US adults, 1999–2008.
JAMA. 303:235–241. 2010.
|
|
3
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Antuna-Puente B, Feve B, Fellahi S and
Bastard JP: Adipokines: the missing link between insulin resistance
and obesity. Diabetes Metab. 34:2–11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Facchini FS, Hua N, Abbasi F and Reaven
GM: Insulin resistance as a predictor of age-related diseases. J
Clin Endocrinol Metab. 86:3574–3578. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Larsson SC, Mantzoros CS and Wolk A:
Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J
Cancer. 121:856–862. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pisani P: Hyper-insulinaemia and cancer,
meta-analyses of epidemiological studies. Arch Physiol Biochem.
114:63–70. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Verheus M, Peeters PH, Rinaldi S, Dossus
L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M,
Clavel-Chapelon F, Tehard B, Nagel G, Linseisen J, Boeing H,
Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D,
Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH,
Buenode-Mesquita BH, Gonzalez CA, Ardanaz E, Larranaga N, Garcia
CM, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT,
Slimani N, Riboli E and Kaaks R: Serum C-peptide levels and breast
cancer risk: results from the European Prospective Investigation
into Cancer and Nutrition (EPIC). Int J Cancer. 119:659–667. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gunter MJ, Hoover DR, Yu H,
Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X,
Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk
RD and Strickler HD: Insulin, insulin-like growth factor-I, and
risk of breast cancer in postmenopausal women. J Natl Cancer Inst.
101:48–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garmendia ML, Pereira A, Alvarado ME and
Atalah E: Relation between insulin resistance and breast cancer
among Chilean women. Ann Epidemiol. 17:403–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Del Giudice ME, Fantus IG, Ezzat S,
McKeown-Eyssen G, Page D and Goodwin PJ: Insulin and related
factors in premenopausal breast cancer risk. Breast Cancer Res
Treat. 47:111–120. 1998.PubMed/NCBI
|
|
12
|
Goodwin PJ, Ennis M, Pritchard KI, Trudeau
ME, Koo J, Madarnas Y, Hartwick W, Hoffman B and Hood N: Fasting
insulin and outcome in early-stage breast cancer: results of a
prospective cohort study. J Clin Oncol. 20:42–51. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eliassen AH, Tworoger SS, Mantzoros CS,
Pollak MN and Hankinson SE: Circulating insulin and c-peptide
levels and risk of breast cancer among predominately premenopausal
women. Cancer Epidemiol Biomarkers Prev. 16:161–164. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alokail MS, Al-Daghri NM, Al-Attas OS and
Hussain T: Combined effects of obesity and type 2 diabetes
contribute to increased breast cancer risk in premenopausal women.
Cardiovasc Diabetol. 8:332009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Purohit A, Newman SP and Reed MJ: The role
of cytokines in regulating estrogen synthesis: implications for the
etiology of breast cancer. Breast Cancer Res. 4:65–69. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stephenson GD and Rose DP: Breast cancer
and obesity: an update. Nutr Cancer. 45:1–16. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lanzino M, Morelli C, Garofalo C, Panno
ML, Mauro L, Ando S and Sisci D: Interaction between estrogen
receptor alpha and insulin/IGF signaling in breast cancer. Curr
Cancer Drug Targets. 8:597–610. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Straus DS: Growth-stimulatory actions of
insulin in vitro and in vivo. Endocr Rev. 5:356–369. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Whittaker J, Okamoto AK, Thys R, Bell GI,
Steiner DF and Hofmann CA: High-level expression of human insulin
receptor cDNA in mouse NIH 3T3 cells. Proc Natl Acad Sci USA.
84:5237–5241. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Osborne CK, Bolan G, Monaco ME and Lippman
ME: Hormone responsive human breast cancer in long-term tissue
culture: effect of insulin. Proc Natl Acad Sci USA. 73:4536–4540.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Costantino A, Milazzo G, Giorgino F, Russo
P, Goldfine ID, Vigneri R and Belfiore A: Insulin-resistant
MDA-MB231 human breast cancer cells contain a tyrosine kinase
inhibiting activity. Mol Endocrinol. 7:1667–1676. 1993.PubMed/NCBI
|
|
22
|
Monaco ME and Lippman ME: Insulin
stimulation of fatty acid synthesis in human breast cancer in long
term tissue culture. Endocrinology. 101:1238–1246. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gross GE, Boldt DH and Osborne CK:
Perturbation by insulin of human breast cancer cell cycle kinetics.
Cancer Res. 44:3570–3575. 1984.PubMed/NCBI
|
|
24
|
Geier A, Beery R, Haimshon M, Hemi R and
Lunenfeld B: Serum and insulin inhibit cell death induced by
cycloheximide in the human breast cancer cell line MCF-7. In Vitro
Cell Dev Biol. 28A:415–418. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Faridi J, Fawcett J, Wang L and Roth RA:
Akt promotes increased mammalian cell size by stimulating protein
synthesis and inhibiting protein degradation. Am J Physiol
Endocrinol Metab. 285:E964–E972. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Godden J, Leake R and Kerr DJ: The
response of breast cancer cells to steroid and peptide growth
factors. Anticancer Res. 12:1683–1688. 1992.PubMed/NCBI
|
|
27
|
Papa V, Milazzo G, Goldfine ID, Waldman FM
and Vigneri R: Sporadic amplification of the insulin receptor gene
in human breast cancer. J Endocrinol Invest. 20:531–536. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Weichhaus M, Broom I and Bermano G: The
molecular contribution of TNF-α in the link between obesity and
breast cancer. Oncol Rep. 25:477–483. 2011.
|
|
29
|
Lorincz AM and Sukumar S: Molecular links
between obesity and breast cancer. Endocr Relat Cancer. 13:279–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Osborne CK, Monaco ME, Lippman ME and Kahn
CR: Correlation among insulin binding, degradation, and biological
activity in human breast cancer cells in long-term tissue culture.
Cancer Res. 38:94–102. 1978.PubMed/NCBI
|
|
31
|
Hirose K, Toyama T, Iwata H, Takezaki T,
Hamajima N and Tajima K: Insulin, insulin-like growth factor-I and
breast cancer risk in Japanese women. Asian Pac J Cancer Prev.
4:239–246. 2003.PubMed/NCBI
|
|
32
|
Belfiore A, Costantino A, Frasca F,
Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID and Vigneri R:
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast
cancer cells is associated with inhibition of insulin receptor
tyrosine kinase activity. Mol Endocrinol. 10:1318–1326.
1996.PubMed/NCBI
|
|
33
|
Papa V, Pezzino V, Costantino A, Belfiore
A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID and
Vigneri R: Elevated insulin receptor content in human breast
cancer. J Clin Invest. 86:1503–1510. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hollestelle A, Elstrodt F, Nagel JH,
Kallemeijn WW and Schutte M: Phosphatidylinositol-3-OH kinase or
RAS pathway mutations in human breast cancer cell lines. Mol Cancer
Res. 5:195–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
